ELYM Old Analysis

ELYMDelisted Stock  USD 3.09  0.06  1.90%   
ELYM Old is overvalued with Real Value of 2.94 and Hype Value of 3.38. The main objective of ELYM Old delisted stock analysis is to determine its intrinsic value, which is an estimate of what ELYM Old is worth, separate from its market price. There are two main types of ELYM Old's stock analysis: fundamental analysis and technical analysis.
The ELYM Old stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. ELYM Old is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. ELYM Stock trading window is adjusted to America/New York timezone.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

ELYM Stock Analysis Notes

About 78.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.99. Some equities with similar Price to Book (P/B) outperform the market in the long run. ELYM Old recorded a loss per share of 2.22. The entity had not issued any dividends in recent years. Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington. Eliem Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people. To learn more about ELYM Old call BAO BCh at 877 354 3689 or check out https://eliemtx.com.

ELYM Old Investment Alerts

ELYM Old is now traded under the symbol CLYM. Please update your portfolios or report it if you believe this is an error. Report It!
ELYM Old is not yet fully synchronised with the market data
ELYM Old generated a negative expected return over the last 90 days
ELYM Old has high historical volatility and very poor performance
ELYM Old has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (35.12 M) with profit before overhead, payroll, taxes, and interest of 0.
ELYM Old currently holds about 122.95 M in cash with (20.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.63, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 78.0% of the company shares are held by institutions such as insurance companies

ELYM Old Upcoming and Recent Events

4th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

ELYM Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 342.68 M.

ELYM Old Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ELYM Old insiders, such as employees or executives, is commonly permitted as long as it does not rely on ELYM Old's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ELYM Old insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Emily Pimblett over three months ago
Disposition of tradable shares by Emily Pimblett of Eliem Therapeutics at 8.06 subject to Rule 16b-3
 
Valerie Morisset over three months ago
Disposition of 10201 shares by Valerie Morisset of Eliem Therapeutics at 7.09 subject to Rule 16b-3
 
Valerie Morisset over three months ago
Disposition of 30000 shares by Valerie Morisset of Eliem Therapeutics at 7.98 subject to Rule 16b-3
 
Valerie Morisset over three months ago
Disposition of 50000 shares by Valerie Morisset of Eliem Therapeutics at 7.13 subject to Rule 16b-3
 
Valerie Morisset over three months ago
Disposition of 42377 shares by Valerie Morisset of Eliem Therapeutics at 7.01 subject to Rule 16b-3
 
Valerie Morisset over three months ago
Disposition of 50000 shares by Valerie Morisset of Eliem Therapeutics at 7.11 subject to Rule 16b-3
 
Valerie Morisset over six months ago
Disposition of 12342 shares by Valerie Morisset of Eliem Therapeutics at 7.06 subject to Rule 16b-3
 
Ratcliffe Liam over six months ago
Acquisition by Ratcliffe Liam of 10000 shares of Eliem Therapeutics at 7.89 subject to Rule 16b-3
 
Emily Pimblett over six months ago
Disposition of 1245 shares by Emily Pimblett of Eliem Therapeutics at 7.2145 subject to Rule 16b-3
 
Emily Pimblett over six months ago
Acquisition by Emily Pimblett of 5000 shares of Eliem Therapeutics subject to Rule 16b-3
 
Valerie Morisset over six months ago
Acquisition by Valerie Morisset of 255219 shares of Eliem Therapeutics at 0.002 subject to Rule 16b-3
 
Ratcliffe Liam over six months ago
Disposition of tradable shares by Ratcliffe Liam of Eliem Therapeutics subject to Rule 16b-3

ELYM Old Predictive Daily Indicators

ELYM Old intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ELYM Old stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About ELYM Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how ELYM Old prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ELYM shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as ELYM Old. By using and applying ELYM Stock analysis, traders can create a robust methodology for identifying ELYM entry and exit points for their positions.
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington. Eliem Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ELYM Old to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Share Portfolio Now

   

Share Portfolio

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Consideration for investing in ELYM Stock

If you are still planning to invest in ELYM Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ELYM Old's history and understand the potential risks before investing.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.